Efficacy and Safety of Adding Atracurium to Percaruncular Block for High Myopes Undergoing Cataract Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

May 1, 2015

Primary Completion Date

May 1, 2016

Study Completion Date

May 1, 2016

Conditions
Quality of Ocular Akinesia (Onset and Duration)
Interventions
DRUG

Atracurium

5mg in 1 ml normal saline

DRUG

Lidocaine 2%

DRUG

Bupivacaine 0.5%

DRUG

hyaluronidase powder

1500 iu powder diluted in 2 vial lidocaine 20 ml resulting 37.5 IU/ml lidocaine and 93.7 / 2.5 ml lidocaine or 15.6 IU/ml of the 6 ml solution

PROCEDURE

per-caruncular peribulbar injection

The patient will lie in a supine position and the eyes are in the neutral position. The needle (25 Gauge (G), 25 mm) insertion point will be just medial to the caruncle, directly perpendicular to the face and parallel to the medial orbital wall to 15-20 mm depth. After negative aspiration the already chosen local anesthetic mixture will be injected slowly. During injection, the globe will be palpated with one finger and tension in the lids will be tested frequently, if the lids become tense or if the tension is felt to rise in the globe, the injection will be stopped. After injection, external compression with Honan balloon inflated to 20-30 mm Hg will be applied for 10 minutes and will be removed every 2 minutes to test akinesia and anesthesia

Trial Locations (1)

11562

Kasr Alaini Hospital, Cairo

All Listed Sponsors
lead

Kasr El Aini Hospital

OTHER

NCT03243500 - Efficacy and Safety of Adding Atracurium to Percaruncular Block for High Myopes Undergoing Cataract Surgery | Biotech Hunter | Biotech Hunter